Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (111-120 of 265) with videos related to

Pageof 27
Sort By:
The Journal of Urology|May 29, 2003
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostateCharles J Rosser, Lawrence B Levy, Deborah A Kuban, et al.
International Journal of Surgical Pathology|May 6, 2022
Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the ProstateOleksandr N Kryvenko, Sanoj Punnen, Thirupandiyur S Udayakumar, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancerRobert A Price, Jean-Michel Hannoun-Levi, Eric Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2007
Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivoRadka Stoyanova, Paul Hachem, Harvey Hensley, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Gains from real-time tracking of prostate motion during external beam radiation therapyJin Sheng Li, Lihui Jin, Alan Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapyDidier Cowen, Patricia Troncoso, Vincent S Khoo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancerAndre Konski, Deborah Watkins-Bruner, Steven Feigenberg, et al.
The Journal of Urology|October 24, 2002
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancerCharles J Rosser, Deborah A Kuban, Lawrence B Levy, et al.
Frontiers in Oncology|February 13, 2015
Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active SurveillanceKiri Sandler, Mausam Patel, Charles Lynne, et al.
The American Journal of Surgical Pathology|May 10, 2016
Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template BiopsyOleksandr N Kryvenko, Kirill Lyapichev, Felix M Chinea, et al.
Pageof 27

Showing results (111-120 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Urology|May 29, 2003
Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostateCharles J Rosser, Lawrence B Levy, Deborah A Kuban, et al.
International Journal of Surgical Pathology|May 6, 2022
Experimental Support for the Possibility of Retrograde Genesis of Intraductal Carcinoma of the ProstateOleksandr N Kryvenko, Sanoj Punnen, Thirupandiyur S Udayakumar, et al.
International Journal of Radiation Oncology, Biology, Physics|September 13, 2006
Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancerRobert A Price, Jean-Michel Hannoun-Levi, Eric Horwitz, et al.
International Journal of Radiation Oncology, Biology, Physics|July 20, 2007
Antisense-MDM2 sensitizes LNCaP prostate cancer cells to androgen deprivation, radiation, and the combination in vivoRadka Stoyanova, Paul Hachem, Harvey Hensley, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Gains from real-time tracking of prostate motion during external beam radiation therapyJin Sheng Li, Lihui Jin, Alan Pollack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Ki-67 staining is an independent correlate of biochemical failure in prostate cancer treated with radiotherapyDidier Cowen, Patricia Troncoso, Vincent S Khoo, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancerAndre Konski, Deborah Watkins-Bruner, Steven Feigenberg, et al.
The Journal of Urology|October 24, 2002
Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancerCharles J Rosser, Deborah A Kuban, Lawrence B Levy, et al.
Frontiers in Oncology|February 13, 2015
Multiparametric-MRI and Targeted Biopsies in the Management of Prostate Cancer Patients on Active SurveillanceKiri Sandler, Mausam Patel, Charles Lynne, et al.
The American Journal of Surgical Pathology|May 10, 2016
Radical Prostatectomy Findings in White Hispanic/Latino Men With NCCN Very Low-risk Prostate Cancer Detected by Template BiopsyOleksandr N Kryvenko, Kirill Lyapichev, Felix M Chinea, et al.
Pageof 27